These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 17367405

  • 1. Upregulation of the brain renin-angiotensin system in rats with chronic renal failure.
    Nishimura M, Takahashi H, Yoshimura M.
    Acta Physiol (Oxf); 2007 Apr; 189(4):369-77. PubMed ID: 17367405
    [Abstract] [Full Text] [Related]

  • 2. Roles of central renin-angiotensin system and afferent renal nerve in the control of systemic hemodynamics in rats.
    Fujisawa Y, Nagai Y, Lei B, Nakano D, Fukui T, Hitomi H, Mori H, Masaki T, Nishiyama A.
    Hypertens Res; 2011 Nov; 34(11):1228-32. PubMed ID: 21796126
    [Abstract] [Full Text] [Related]

  • 3. Developmental activity of the renin-angiotensin system during the "critical period" modulates later L-NAME-induced hypertension and renal injury.
    Ishiguro K, Sasamura H, Sakamaki Y, Itoh H, Saruta T.
    Hypertens Res; 2007 Jan; 30(1):63-75. PubMed ID: 17460373
    [Abstract] [Full Text] [Related]

  • 4. Kinin and angiotensin II receptor antagonists in rats with chronic renal failure: chronic effects on cardio- and renoprotection of angiotensin converting enzyme inhibitors.
    Kohzuki M, Kanazawa M, Liu PF, Kamimoto M, Yoshida K, Saito T, Yasujima M, Sato T, Abe K.
    J Hypertens; 1995 Dec; 13(12 Pt 2):1785-90. PubMed ID: 8903652
    [Abstract] [Full Text] [Related]

  • 5. Role of angiotensin II in cerebrovascular and renal damage in deoxycorticosterone acetate-salt hypertensive rats.
    Wada T, Kanagawa R, Ishimura Y, Inada Y, Nishikawa K.
    J Hypertens; 1995 Jan; 13(1):113-22. PubMed ID: 7759841
    [Abstract] [Full Text] [Related]

  • 6. [Molecular mechanisms of nephro-protective action of enalapril in experimental chronic renal failure].
    Ciechanowicz A.
    Ann Acad Med Stetin; 1999 Jan; Suppl 52():1-93. PubMed ID: 10589103
    [Abstract] [Full Text] [Related]

  • 7. Renal protective effects of angiotensin II receptor I antagonist CV-11974 in spontaneously hypertensive stroke-prone rats (SHR-sp).
    Nakamura T, Honma H, Ikeda Y, Kuroyanagi R, Takano H, Obata J, Sato T, Kimura H, Yoshida Y, Tamura K.
    Blood Press Suppl; 1994 Jan; 5():61-6. PubMed ID: 7889203
    [Abstract] [Full Text] [Related]

  • 8. Tempol or candesartan prevents high-fat diet-induced hypertension and renal damage in spontaneously hypertensive rats.
    Chung S, Park CW, Shin SJ, Lim JH, Chung HW, Youn DY, Kim HW, Kim BS, Lee JH, Kim GH, Chang YS.
    Nephrol Dial Transplant; 2010 Feb; 25(2):389-99. PubMed ID: 19749146
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Effects of CS-866, an angiotensin II receptor antagonist, in 5/6 nephrectomized spontaneously hypertensive rats].
    Xu HL, Yoshida K, Wu XM, Kohzuki M.
    Nihon Jinzo Gakkai Shi; 2001 Oct; 43(7):580-8. PubMed ID: 11725555
    [Abstract] [Full Text] [Related]

  • 11. Short-term treatment of stroke-prone spontaneously hypertensive rats with an AT1 receptor blocker protects against hypertensive end-organ damage by prolonged inhibition of the renin-angiotensin system.
    Hamaguchi R, Takemori K, Inoue T, Masuno K, Ito H.
    Clin Exp Pharmacol Physiol; 2008 Oct; 35(10):1151-5. PubMed ID: 18518883
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of an ARB on endothelial progenitor cell function and cardiovascular oxidation in hypertension.
    Yu Y, Fukuda N, Yao EH, Matsumoto T, Kobayashi N, Suzuki R, Tahira Y, Ueno T, Matsumoto K.
    Am J Hypertens; 2008 Jan; 21(1):72-7. PubMed ID: 18091747
    [Abstract] [Full Text] [Related]

  • 16. Renal and extra-renal renin gene expression in spontaneously hypertensive rats.
    Okura T, Kitami Y, Wakamiya R, Marumoto K, Iwata T, Hiwada K.
    Blood Press Suppl; 1992 Jan; 3():6-11. PubMed ID: 1343292
    [Abstract] [Full Text] [Related]

  • 17. Candesartan and insulin reduce renal sympathetic nerve activity in hypertensive type 1 diabetic rats.
    Takimoto C, Kumagai H, Osaka M, Sakata K, Onami T, Kamayachi T, Iigaya K, Hayashi K, Saruta T, Itoh H.
    Hypertens Res; 2008 Oct; 31(10):1941-51. PubMed ID: 19015602
    [Abstract] [Full Text] [Related]

  • 18. Angiotensin-converting enzyme and angiotensin II receptor subtype 1 inhibitors restitute hypertensive internal anal sphincter in the spontaneously hypertensive rats.
    De Godoy MA, Rattan S.
    J Pharmacol Exp Ther; 2006 Aug; 318(2):725-34. PubMed ID: 16648368
    [Abstract] [Full Text] [Related]

  • 19. Oral carbonaceous absorbent modifies renal function of renal ablation model without affecting plasma renin-angiotensin system or protein intake.
    Horike K, Usami T, Kamiya Y, Kamiya T, Yoshida A, Itoh S, Yamato H, Ise M, Kimura G.
    Clin Exp Nephrol; 2003 Jun; 7(2):120-4. PubMed ID: 14586730
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.